Straight to the source – targeted pain relief
Diamyd Medical, a Swedish biopharmaceutical company, has taken huge steps towards revolutionising the treatment of intractable pain. Through their Nerve Targeting Drug Delivery System (NTDDS) the developers hope to bring new relief to cancer, diabetes and chronic pain sufferers. Dr Nicola Davies reports.
A more permeable pathway – next generation transdermal drug delivery
Researchers at MIT have discovered a way to make skin more permeable by using ultrasound waves, opening up the possibility of transdermal patches delivering larger molecular drugs. Heidi Vella discovers what this new research and other next generation transdermal patches could mean for the future of conventional drug delivery.
Breaking barriers – the potential of subcutaneous drug delivery
Cancer rates are rising sharply just as healthcare providers are being asked to implement enormous efficiency savings, making innovation crucial to the future of cancer care. Elly Earls met Halozyme's Kurt Gustafson and Roche Products' Julian Cole, to find out how a revolutionary new subcutaneous drug delivery platform called ENHANZE™ could be part of the solution.
Imperial marches into Africa - building a drug supply chain
Africa's dire need for pharmaceuticals is well-documented, but so are logistical problems involved in transporting sensitive drugs across long distances in the continent's tropical climate and harsh terrain. Dr Nicola Davies spoke to Johannesburg-based Imperial Holdings, who recently made a bold move to improve their logistics chain by acquiring the pharmaceutical and consumer healthcare supply chain of South Africa's RTT Group.
Tumour-targeting ADCs: delivering the anti-cancer warhead
Antibody-drug conjugates combine the efficacy of cytotoxic drugs and the tumour-specific targeting of antibodies to maximise anti-cancer potency and minimise side effects. Chris Lo talks to experts in the field of ADC development to discover the potential of this burgeoning treatment type, and the challenges involved in getting it right.